Impact of Prolonged Impella 5.5 Support on Post‐Transplant Outcomes: An Institutional Study
Clinical Transplantation · 2026
DOI: 10.1111/ctr.70452 ↗At a glance
Journal article in Clinical Transplantation, 2026. Written by David Rekhtman and 12 co-authors. Institution: Division of Cardiovascular Surgery, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA. Major MEDLINE topics: Heart Transplantation, Heart-Assist Devices, Postoperative Complications, Graft Rejection. Cited 1 times so far (Crossref); 28 references. The full text is freely available (open access, CC BY 4.0).
Abstract (original language)
Objectives
Microaxial flow pump devices are utilized as a bridge to heart transplantation for patients in advanced cardiogenic shock. Little is known about the impact of device duration on post‐transplant outcomes. This study aims to compare post‐transplantation outcomes based on duration of support with the Impella 5.5.
Methods
All patients who were successfully bridged to transplant on the Impella 5.5 platform were included and stratified based on support duration (≤ 14 days vs. > 14 days). Baseline clinical characteristics were collected throughout the index admission. Outcomes included 1‐year mortality, complications during the index admission, graft rejection, and rehospitalization within the first year.
Results
Of the 72 patients successfully bridged to transplant, 64% (n = 46) were supported for more than 14 days. When stratified by duration of Impella 5.5 use, there were no differences in pretransplantation clinical status. Length of stay (26 vs. 20 days, p = 0.316) and rates of home discharges (65% vs. 67%, p = 0.524) were similar. Despite a high prevalence of rehospitalization at 1 year (75%), the 1‐year survival was 96% and similar between the two cohorts ( p = 0.289).
Conclusions
Use of a prolonged microaxial flow pump may be a safe bridging strategy for heart transplantation given comparable post‐transplant outcomes for patients stratified by support duration.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Division of Cardiovascular Surgery, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
- Division of Cardiovascular Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
ORCID profiles: David Rekhtman, Cindy Song, Max Shin, Michael Catalano
Cite
APA
Rekhtman, D., Iyengar, A., Song, C., Asher, M., Shin, M., Catalano, M., Toubat, O., Morganroth, E., Brown, A., Wald, J., Parikh, A., Biscotti, M., & Cevasco, M. (2026). Impact of Prolonged Impella 5.5 Support on Post‐Transplant Outcomes: An Institutional Study. Clinical Transplantation. https://doi.org/10.1111/ctr.70452
Vancouver
Rekhtman D, Iyengar A, Song C, Asher M, Shin M, Catalano M, et al. Impact of Prolonged Impella 5.5 Support on Post‐Transplant Outcomes: An Institutional Study. Clinical Transplantation. 2026. doi:10.1111/ctr.70452
BibTeX
@article{Rekhtman2026,
author = {Rekhtman, David and Iyengar, Amit and Song, Cindy and Asher, Michaela and Shin, Max and Catalano, Michael and Toubat, Omar and Morganroth, Emma and Brown, Alyson and Wald, Joyce and Parikh, Aditya and Biscotti, Mauer and Cevasco, Marisa},
title = {Impact of Prolonged Impella 5.5 Support on Post‐Transplant Outcomes: An Institutional Study},
journal = {Clinical Transplantation},
year = {2026},
doi = {10.1111/ctr.70452}
}
EUVIMED